GlassScriptPhysician profile
Michael F Shank
NPI 1720056336
$1,402.55
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $50.91 · 2021: $941 · 2022: $59.61 · 2023: $41.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $41.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $41.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $825.00 | 2021 | |
| Novo Nordisk INC | $121.42 | 2019-2021 | |
| Hologic Sales and Service, LLC | $60.81 | 2022-2023 | Aptima, Thinprep 2000 Processor |
| Acorda Therapeutics, INC | $52.75 | 2019 | |
| Pfizer INC. | $32.59 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $30.90 | 2019 | |
| Janssen Pharmaceuticals, INC | $30.24 | 2021 | |
| Abbvie INC. | $29.45 | 2021 | |
| Astellas Pharma US INC | $26.90 | 2019 | |
| Acadia Pharmaceuticals INC | $24.45 | 2019 | |
| Boston Scientific Corporation | $23.14 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $22.59 | 2020 | |
| Amgen INC. | $19.45 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.53 | 2019 | |
| Medtronic, INC. | $16.66 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $16.34 | 2019 | |
| Strongbridge US INC. | $15.79 | 2020 | |
| Endo Pharmaceuticals INC. | $12.53 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $11.62 | 2019 | |
| Nevro Corp. | $11.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Shank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.